The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Loperamide Hydrochloride
Loperamide Hydrochloride oral · LOPERAMIDE HYDROCHLORIDE 1 mg/7.5mL · Solution · Oral · Bionpharma Inc.
NDC 69452-0405-55 · 120 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA220100
- TE code
- —
- Approval date
- Sep 19, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Loperamide Hydrochloride oral (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bionpharma Inc. | LOPERAMIDE HYDROCHLORIDE 1 mg/7.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Bionpharma Inc. | LOPERAMIDE HYDROCHLORIDE 1 mg/7.5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Loperamide Hydrochloride — NDC 69452-0405-55," retrieved September 3, 2026, https://drugdashboards.com/drug/69452040555.
Free to cite with attribution — see how the data is put together.